Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed aprepitant administration with docetaxel + cisplatin chemotherapy for CINV and docetaxel pharmacokinetics
ChiCTR1800016704Phase 4Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by The Second Xiangya Hospital. Primary endpoints: Clinical index and Blood concentration. Started Oct 2017; status: completed.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR1800016704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016704.